TAK-593

DB13093InvestigationalSmall molecule

TAK-593 has been used in trials studying the treatment of Solid Tumors.

Chemical structure of TAK-593
Mechanism
Curator reviewed
Formula / weight
C23H23N7O3 · 445.483 g/mol (avg)
Code names
TAK 593

Resolves to

Compound
UNIIH3I42X8XX7CAS1005780-62-0ChEMBLCHEMBL2180604PubChem24767976
Structure
InChIKeyDZFZXPPHBWCXPQ-UHFFFAOYSA-NSMILESCN1N=C(C)C=C1C(=O)NC1=CC(OC2=NN3C=C(NC(=O)C4CC4)N=C3C=C2)=CC=C1C
Targets
P09619PDGFRBP35968KDR

What you can answer from here — as of June 15, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
8+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with TAK-593, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In